Results per Page:
Driver’s ed: watching HSV co-infection and recombination in vivo
From the Jerome Lab, Vaccine & Infectious Disease Division
Anti-(idio)typical: a new immunogen to vaccinate against RSV
From the McGuire Lab, Vaccine & Infectious Disease Division
Inching closer to an EBV vaccine?
From the McGuire lab, Vaccine and Infectious Diseases Division
Uncovering the secrets of HIV latency
From the Cohn lab, Vaccine and Infectious Disease Division
New strategy to weather the (cytokine) storm
From the Gujral Lab, Human Biology Division
Face masks: simple and effective
From the Schiffer group, Vaccine and Infectious Disease Division
Few variants arise from acute SARS-CoV-2 infections
From the University of Wisconsin-Madison and the Fred Hutch Vaccine and Infectious Disease Division
One-in-four cancer patients lack immunity to measles
From the Vaccine and Infectious Disease Division and the Fred Hutch/University of Washington Cancer Consortium
Antiviral cytokines pick up T cell slack
From the Schiffer group, Vaccine and Infectious Disease Division
Multi-step HIV-1 vaccines
From the Vaccine and Infectious Disease Division and the Chan Zuckerberg Biohub.
Screening with bioinformatics for new dengue cross-serotype antibodies
From the Vaccine and Infectious Disease Division and the Chan Zuckerberg Biohub.